Susquehanna International Group
OSIR

Susquehanna International Group’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Susquehanna International Group’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-49,500
Closed -$941K – 11356
2019
Q1 		$941K Buy
+49,500
New +$803K ﹤0.01% 5163
2017
Q1 		– Sell
-10,900
Closed -$54K – 10913
2016
Q4 		$54K Buy
+10,900
New +$55.8K ﹤0.01% 9276
2016
Q2 		– Sell
-69,700
Closed -$398K – 10097
2016
Q1 		$398K Sell
69,700
-70,000
-50% -$489K ﹤0.01% 6792
2015
Q4 		$1.45M Buy
139,700
+25,400
+22% +$345K ﹤0.01% 4680
2015
Q3 		$2.11M Buy
114,300
+24,100
+27% +$465K ﹤0.01% 4169
2015
Q2 		$1.75M Sell
90,200
-60,400
-40% -$1.07M ﹤0.01% 4998
2015
Q1 		$2.65M Sell
150,600
-162,100
-52% -$2.72M ﹤0.01% 3768
2014
Q4 		$5M Buy
312,700
+165,900
+113% +$2.22M ﹤0.01% 2890
2014
Q3 		$1.85M Buy
146,800
+28,000
+24% +$399K ﹤0.01% 4748
2014
Q2 		$1.86M Sell
118,800
-116,000
-49% -$1.71M ﹤0.01% 4806
2014
Q1 		$3.08M Buy
234,800
+25,500
+12% +$399K ﹤0.01% 3601
2013
Q4 		$3.37M Buy
209,300
+87,300
+72% +$1.39M ﹤0.01% 3496
2013
Q3 		$2.03M Buy
122,000
+97,900
+406% +$1.45M ﹤0.01% 4074
2013
Q2 		$243K Buy
+24,100
New +$253K ﹤0.01% 7159

Other funds holding OSIR

FGAM
Financial Gravity Asset Management Lakeway, Texas $562M AUM

Susquehanna International Group's OSIR Position: Q2 2019 in Review

Susquehanna International Group sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 175,223 shares — an estimated $3.33M sold.

Susquehanna International Group first reported a position in OSIR in Q2 2013 and held it in 16 quarters. The position peaked at $3.65M in Q4 2014. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

  • Susquehanna International Group reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Susquehanna International Group sold 175,223 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $3.33M.
  • Susquehanna International Group first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 16 quarters.
  • Susquehanna International Group's Osiris Therapeutics, Inc. Common Stock position peaked at $3.65M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Susquehanna International Group's 13F filing for Q2 2019, filed 14 Aug 2019.